"Prescription Fees" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The charge levied on the consumer for drugs or therapy prescribed under written order of a physician or other health professional.
| Descriptor ID |
D011306
|
| MeSH Number(s) |
N03.219.442.551.621
|
| Concept/Terms |
Prescription Fees- Prescription Fees
- Dispensing Fees
- Dispensing Fee
- Fee, Dispensing
- Fees, Dispensing
- Fees, Prescription
- Fee, Prescription
- Prescription Fee
|
Below are MeSH descriptors whose meaning is more general than "Prescription Fees".
Below are MeSH descriptors whose meaning is more specific than "Prescription Fees".
This graph shows the total number of publications written about "Prescription Fees" by people in this website by year, and whether "Prescription Fees" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prescription Fees" by people in Profiles.
-
Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017. Circulation. 2019 12 17; 140(25):2067-2075.
-
Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries. J Clin Oncol. 2017 Aug 01; 35(22):2482-2489.
-
In Reply--Lowering the High Cost of Cancer Drugs. Mayo Clin Proc. 2016 Mar; 91(3):401-3.
-
Strategies that delay or prevent the timely availability of affordable generic drugs in the United States. Blood. 2016 Mar 17; 127(11):1398-402.
-
Development of a metrics dashboard for monitoring involvement in the 340B Drug Pricing Program. Am J Health Syst Pharm. 2015 Sep 01; 72(17):1489-95.
-
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
-
Predictors of $4 generic prescription drug discount programs use in the low-income population. Res Social Adm Pharm. 2014 Jan-Feb; 10(1):141-8.
-
Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer. Gynecol Oncol. 2012 Oct; 127(1):18-21.
-
Federally qualified health center patients and generic drug discount programs. J Health Care Poor Underserved. 2012 May; 23(2):875-83.
-
Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother. 2004; 18(1):59-70.